PMID: 11276171Mar 29, 2001Paper

The perimenopause, depressive disorders, and hormonal variability

São Paulo Medical Journal = Revista Paulista De Medicina
C N Soares, L S Cohen

Abstract

Several investigations have postulated that the perimenopause may represent a period of increased psychiatric vulnerability, particularly for mood disorders. This review characterizes the perimenopause, including biological changes, the influence of psychosocial factors and the most common clinical manifestations. Clinic-based studies and community-based surveys addressing the prevalence of depressive symptoms in perimenopausal women are critically reviewed. We also discuss the potential greater vulnerability to mood disturbance during the perimenopause in response to hormonal variability. A therapeutic algorithm for management of depressive symptoms in middle-aged perimenopausal women is also presented. The role of estrogen in the treatment of perimenopausal depressive symptoms is particularly discussed. In addition, we review the existing data regarding the potential efficacy of estrogen as an antidepressant agent (monotherapy, augmentation strategy or prophylaxis). Narrative review.

References

Jul 30, 1977·The Medical Journal of Australia·M A SchneiderJ Hailes
Jan 1, 1978·Acta Obstetricia Et Gynecologica Scandinavica·F C Chrétien
Jul 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·C B Ballinger
Jul 1, 1991·The American Journal of Psychiatry·P J Schmidt, D R Rubinow
Nov 1, 1990·Epidemiology·A S Midgette, J A Baron
Nov 1, 1990·Maturitas·J JensenC Christiansen
Feb 1, 1990·Journal of Behavioral Medicine·L C SwartzmanE Kemmann
Mar 1, 1986·Culture, Medicine and Psychiatry·M Lock
Feb 1, 1987·American Journal of Obstetrics and Gynecology·E AndersonR W Rebar
May 1, 1974·British Journal of Preventive & Social Medicine·S M McKinlay, M Jefferys
Jul 19, 1980·British Medical Journal·G T BungayC K McPherson
Dec 1, 1981·Maturitas·A E Treloar
Jun 15, 1995·American Journal of Epidemiology·B L HarlowK M Annis
May 1, 1995·Acta Obstetricia Et Gynecologica Scandinavica·J KarlbergI Wiklund
May 1, 1994·Experimental Gerontology·M Lock
Mar 1, 1994·Maturitas·C A MorseH Burger
Apr 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·A G HayE C Johnstone
Mar 1, 1996·Maturitas·S M McKinlay
Dec 15, 1995·Biological Psychiatry·D A SichelJ F Rosenbaum
Feb 1, 1997·Seminars in Reproductive Endocrinology·P J SchmidtD R Rubinow
Apr 1, 1997·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·L S SchneiderB S Meyers
Sep 26, 1997·Journal of Psychosomatic Obstetrics and Gynaecology·C Larsson, J Hallman
May 23, 1998·Annual Review of Immunology·H Metzger
Nov 10, 1998·Biological Psychiatry·H Joffe, L S Cohen
Feb 4, 1999·Journal of Psychosomatic Obstetrics and Gynaecology·C A MorseL Dennerstein
Apr 23, 1999·Journal of Psychosomatic Obstetrics and Gynaecology·C Novaes, O P Almeida
Oct 8, 1999·Journal of Affective Disorders·J AmsterdamC Beasley
Jan 26, 2000·Menopause : the Journal of the North American Menopause Society·R R Freedman

❮ Previous
Next ❯

Citations

Aug 15, 2009·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Margaret Diana van DieKerry M Bone
Jul 14, 2011·Neuropsychiatric Disease and Treatment·Chantal Moret, Mike Briley
Nov 17, 2012·Climacteric : the Journal of the International Menopause Society·L A CrayE S Mitchell
Apr 14, 2010·The Psychiatric Clinics of North America·Kristina M Deligiannidis, Marlene P Freeman
Jan 2, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R ZanardiE Smeraldi
Mar 14, 2012·Journal of Clinical Nursing·Carmen Villaverde GutiérrezJesús Ramírez Rodrigo
May 25, 2010·The Journal of Obstetrics and Gynaecology Research·Suely R BelloLigia A Azzalis
Apr 4, 2006·Maturitas·Ozgür OztürkSerdar Ozşener
Jul 14, 2012·São Paulo Medical Journal = Revista Paulista De Medicina·Shahnaz KhaleghipourGholamhossein Ahmadzade
Nov 2, 2006·Menopause : the Journal of the North American Menopause Society·Tetsuro AbeMasatoshi Itoh
Sep 6, 2011·Journal of Psychopharmacology·Erika Estrada-CamarenaOfir Picazo
Jan 1, 2002·Expert Review of Neurotherapeutics·Claudio N SoaresJennifer Prouty
Mar 18, 2016·Journal of Family Medicine and Primary Care·Priya BansalPushapindra Kaushal
Dec 12, 2020·Neuroscience and Biobehavioral Reviews·Rebecca AlexanderCharis Styliadis
Sep 10, 2020·Journal of Affective Disorders·Jasmine WilliUlrike Ehlert
Oct 4, 2020·Sexual & Reproductive Healthcare : Official Journal of the Swedish Association of Midwives·Jasmine Willi, Ulrike Ehlert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.